<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
EXAI
Exscientia
$
()


  • Exscientia files $300M mixed securities shelf

    3/21/2024 - 09:22am
  • Exscientia reports Q4 EPS (42c), consensus (35c)

    3/21/2024 - 07:04am
  • Exscientia sinks 20% after CEO is fired for inappropriate relationships

    2/13/2024 - 10:16am
  • Exscientia downgraded at BofA on limited near-term inflection opportunities

    1/5/2024 - 07:30am
  • BofA gets more bearish on Exscientia, downgrades shares

    1/5/2024 - 06:06am
  • Exscientia expands Sanofi deal, eligible for $45M in milestones plus incentives

    12/21/2023 - 07:10am
  • Exscientia reports Q3 EPS (31c), consensus (40c)

    11/9/2023 - 07:07am
  • Exscientia price target lowered to $10 from $12 at Barclays

    10/17/2023 - 05:55am
  • Exscientia price target lowered to $11 from $16 at BofA

    10/4/2023 - 07:05am
  • Exscientia provided an update on its pipeline prioritisation strategy

    10/3/2023 - 08:44am
  • What You Missed On Wall Street On Wednesday

    9/20/2023 - 16:37pm
  • What You Missed On Wall Street This Morning

    9/20/2023 - 11:57am
  • Fly Intel: Pre-market Movers

    9/20/2023 - 08:56am
  • Exscientia up 31% at $6.62 after entering drug discovery pact with Merck KGaA

    9/20/2023 - 08:28am
  • Exscientia announces drug discovery pact with Merck KGaA

    9/20/2023 - 08:14am
dynamic_feed Breaking News